Dulaglutide-Associated Choroidal Lymphoid Hyperplasia

Key Points

• This study aims to investigate the association between dulaglutide and choroidal lymphoid hyperplasia.
• Randomized trial design
• Participants monitored with retinal imaging
• Assessment of immune responses and biomarkers
• Increased incidence of choroidal lymphoid hyperplasia associated with dulaglutide use
• Enhanced immune response markers observed in affected individuals
• Statistical significance noted with p<0.05 in relevant analyses